Weiye Li MD, PhD
Professor Emeritus of Ophthalmology, Drexel University College of Medicine, Philadelphia, Pennsylvania; Physician, Drexel Eye Physicians, Philadelphia, PennsylvaniaDr. Weiye Li is an Emeritus Professor of Ophthalmology at Drexel University College of Medicine. He served as the Director of both Ophthalmic Research and Retina Services at Drexel.
Dr. Weiye Li received his medical degree from the Second Medical College of Beijing, China, and received his doctorate from the University of Pennsylvania in Philadelphia. He completed a fellowship in retina vitreous diseases at Crozer-Chester Medical Center, Upland, Pennsylvania. Dr. Li was previously Chairman of the Department of Ophthalmology at Peking Union Medical College Hospital, one of the most competitive and internationally respected medical colleges in the People's Republic of China.
Dr. Li’s basic and clinical research focuses on diabetic retinopathy and age-related macular degeneration He is widely published in the field of ophthalmology and has earned many honors and awards for his research. He is also active in many organizations, including the Association of Research in Vision and Ophthalmology.
Recent Contributions to PracticeUpdate:
- A Proposed Classification of Intraretinal Microvascular Abnormalities in Diabetic Retinopathy Following Panretinal Photocoagulation
- Diabetic Retinopathy Screening Using True-Color Wide-Field Confocal Scanner Imaging vs Standard Fundus Photography
- SD-OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for nAMD
- Differences in Parafoveal Vascular Density in Diabetic Patients Without Diabetic Retinopathy
- Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in AMD
- Efficacy and Safety of Ranibizumab With or Without Panretinal Laser Photocoagulation vs Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy
- Brolucizumab: Evolution Through Preclinical and Clinical Studies, and the Implications for the Management of nAMD
- Ranibizumab Treatment in Treatment-Naive Neovascular Age-Related Macular Degeneration
- Intravitreal Ranibizumab for Persistent Diabetic Vitreous Hemorrhage
- Effect of Intravitreal Ranibizumab on Intraretinal Hard Exudates in Eyes With Diabetic Macular Edema